Search research articles
Contact Us
Filters
Showing results (301-310 of 401) with videos related to
Page
of 41
Sort By:
Giornale Italiano Di Cardiologia (2006)
|
November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
Radiology. Cardiothoracic Imaging
|
January 8, 2026
Diagnostic and Prognostic Performance of Pericoronary Adipose Tissue Attenuation in Suspected Acute Coronary Syndrome: Insights from the RAPID-CTCA Trial
Suvasini Lakshmanan, Kang-Ling Wang, Mohammed N Meah, et al.
The New England Journal of Medicine
|
September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Lars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Revista Espanola De Cardiologia (English Ed.)
|
December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal
|
August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Circulation
|
January 19, 2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Ziad Hijazi, John H Alexander, Zhuokai Li, et al.
Journal of the American College of Cardiology
|
January 4, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial
Claes Held, Nils Asenblad, Jean Pierre Bassand, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
American Heart Journal
|
June 27, 2024
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction
Marc-André d'Entremont, Shun Fu Lee, Rajibul Mian, et al.
Page
of 41
Search research articles
Search
Showing results (301-310 of 401) with videos related to
Sort By:
Page
of 41
Giornale Italiano Di Cardiologia (2006)
|
November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
Radiology. Cardiothoracic Imaging
|
January 8, 2026
Diagnostic and Prognostic Performance of Pericoronary Adipose Tissue Attenuation in Suspected Acute Coronary Syndrome: Insights from the RAPID-CTCA Trial
Suvasini Lakshmanan, Kang-Ling Wang, Mohammed N Meah, et al.
The New England Journal of Medicine
|
September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Lars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Revista Espanola De Cardiologia (English Ed.)
|
December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal
|
August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Circulation
|
January 19, 2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Ziad Hijazi, John H Alexander, Zhuokai Li, et al.
Journal of the American College of Cardiology
|
January 4, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial
Claes Held, Nils Asenblad, Jean Pierre Bassand, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
American Heart Journal
|
June 27, 2024
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction
Marc-André d'Entremont, Shun Fu Lee, Rajibul Mian, et al.
Page
of 41